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Conclusion: Accurate midV-CT can be generated using 
freeware. This opens the prospect for its use in our clinical 
practice, allowing treatments in the upper abdomen with 
more adequate CTV-to-PTV margins. For lung cancer patients 
the approach should work even better due to the higher 
contrast images. 
 
Poster: Physics track: (Quantitative) functional and 
biological imaging  
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Purpose or Objective: Radiotracer uptake patterns in FDG-
PET through computation of textural features vcan be used to 
improve characterization of lung cancer lesions for disease 
prognostication and response monitoring and tumor 
delineation purposes. Respiratory motion artefacts cause 
lesion blurring resulting in loss of intra-tumour 
heterogeneity. We have investigated the effect of respiratory 
gating on the recovery of intra-tumour heterogeneity. 
 
Material and Methods: FDG-PET/CT imaging was performed 
in 70 lung cancer patients. Amplitude-based optimal 
respiratory gating (ORG) was performed on bed positions 
covering the thorax. The duty cycle (percentage of the total 
PET data) used for image reconstruction of ORG images was 
35%. Non-gated images were reconstructed using 126 seconds 
of PET data, yielding similar noise characteristics as ORG. 
Lesion segmentation was performed using the fuzzy locally 
adaptive Bayesian (FLAB) algorithm. Four heterogeneity 
parameters (entropy, dissimilarity, zone percentage (ZP), and 
high energy emphasis (HIE)), which have previously shown to 
be robust and associated with survival in lung cancer, were 
calculated in non-gated and ORG images.  
 
Results: Respiratory gating did not result in statistically 
significant differences in the heterogeneity parameters. Sub-
group analysis revealed a significant effect of ORG on the 
heterogeneity parameters of lesions in the lower lobes. The 
mean increase for entropy, dissimilarity, ZP and HIE, 
considering lesions in the lower lobes was 1.3±1.5% (p=0.02), 
11.6±11.8% (p=0.006) 2.3±2.2% (p=0.002), and 16.8%±17.2% 
(p=0.006) respectively. For the centrally located lesions, the 
mean increase for entropy, dissimilarity, ZP and HIE was 
0.58±3.7% (p=0.6), 5.0±19.0% (p=0.4) 0.59±4.0% (p=0.9), and 
4.4±27.8% (p=0.4), respectively. Lesions in the upper lobes 
showed a mean increase of -0.35±1.8 (p=0.3), -1.0±7.7% 
(p=0.3), -0.4±2.7% (p=0.5), -1.7±13.2% (p=0.4), for entropy 
dissimilarity, ZP and HIE, respectively. There was no 
significant correlation between lesion volume and the change 
in parameters between non-gated and ORG images. 
 
Conclusion: Results from this study indicate that ORG 
significantly impacts characterisation of intra-tumour 
heterogeneity, particularly for lesions in the lower lung 
lobes. This suggests that adequate management of 
respiratory motion artefacts is important for improving 
characterisation of intra-tumour heterogeneity in PET. 
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Purpose or Objective: Developing a radiobiologically 
consistent model predicting individual outcome for rectal 
cancer patients (RCPs) treated with an adaptive boost 
approach during neo-adjuvant radiochemotherapy (RCH). 
 
Material and Methods: Forty-two RCPs were treated within a 
prospective observational study. CH consisted of oxaliplatin 
(on days: -14, 0, 14) and 5-fluorouroacil (from day -14 to end) 
being day 0 the start of RT. All patients were treated with 
Helical Tomotherapy (18x2.3Gy) with an adaptive 
concomitant boost technique delivering 3Gy/fr on the 
residual gross tumor volume (GTV) in the last 6 fractions (fr), 
based on MRI imaging taken at fr 9. GTVs were contoured by 
a single radiologist on axial T2 MRI images acquired for initial 
planning (V_PRE), at fr 9 for the adaptive planning (V_MID) 
and before surgery, after a median time of 8.9 weeks after 
the end of RCH (V_POST). Based on a Poisson-like tumor 
regression model and neglecting repopulation and inter-
patient variability of the removal kinetics of killed cells, the 
parameter (1-ΔV(D))^V_PRE was taken as a surrogate of 
tumor control probability (TCP), where ΔV(D)=V_MID/V_PRE 
or V_POST/V_PRE, considering D at fr 9 (TCP_MID) or at the 
end of RCH (TCP_POST). The discriminative power of 
TCP_MID/POST in predicting the pathological complete 
remission (pCR, n=14) was assessed by the AUC of the 
corresponding ROC curves. Then, two-variables logistic (LOG) 
models including V_PRE and ΔV(D) as covariates were also 
considered and the ROC curves of the four models 
(TCP_MID,TCP_POST,LOG_MID, LOG_POST) were compared. 
In addition, an estimate of the residual cells at surgery (V_S) 
was robustly taken as the product of the pathologically 
assessed fraction of viable cells and V_POST. Spearman 
correlation rank test was used to evaluate the correlation 
between the models and V_S. 
 
Results: All models showed a high discriminative power in 
predicting pCR (p-value<0.0001). AUCs for TCP_ MID was 0.87 
(specificity: 71.4%, sensitivity: 96.4%, best cut-off: 5.85), 
higher than TCP_POST (0.82), although the difference did not 
reach significance (p=0.18). TCP_MID/TCP_POST were also 
highly correlated with V_S (R=0.77 and 0.74,p<0.0001). 
Similar performances were found for LOG_MID/LOG_POST 
with AUC=0.90/0.87 and R=0.79/0.77. No significant 
differences were found when comparing TCP models against 
the corresponding LOG models. 
 
 
 
Conclusion: A radiobiologically consistent model including 
early regression (TCP_MID) measured on T2-MRI images well 
predicts pCR and is strongly correlated with the estimated 
residual cells number after adaptive RCH; similar 
performances were obtained with a logistic model including 
V_PRE and V_MID/V_PRE. The corresponding models using 
V_POST showed a slightly, statistically not significant, worse 
